BlackRock Investment Management, LLC - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 29 filers reported holding CASI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$4,0000.0%3,3750.0%0.00%
Q3 2016$4,000
+33.3%
3,375
+20.4%
0.00%
Q2 2016$3,0000.0%2,8020.0%0.00%
Q1 2016$3,0000.0%2,8020.0%0.00%
Q4 2015$3,0000.0%2,8020.0%0.00%
Q3 2015$3,000
-40.0%
2,8020.0%0.00%
Q2 2015$5,0000.0%2,802
-14.5%
0.00%
Q1 2015$5,000
+25.0%
3,2760.0%0.00%
Q4 2014$4,000
-33.3%
3,2760.0%0.00%
Q3 2014$6,0003,2760.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 896,137$4,185,0002.27%
Wellington Shields Capital Management, LLC 888,333$4,149,0000.67%
Manatuck Hill Partners, LLC 15,090$70,0000.03%
IHT Wealth Management, LLC 10,725$50,0000.01%
Perceptive Advisors 43,682$204,0000.01%
ALPS ADVISORS INC 153,234$716,0000.01%
ROYCE & ASSOCIATES LP 78,742$368,0000.00%
MEEDER ASSET MANAGEMENT INC 5,863$28,0000.00%
Tower Research Capital LLC (TRC) 5,974$28,0000.00%
METROPOLITAN LIFE INSURANCE CO/NY 18,585$86,7920.00%
View complete list of CASI PHARMACEUTICALS INC shareholders